Geneva, Switzerland

Serge Christmann-Franck



 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Antony, FR (2013)
  • Geneva, CH (2017 - 2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Serge Christmann-Franck

Introduction

Serge Christmann-Franck is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 4 patents to his name, his work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents are the Macrocyclic pyridazinone derivatives. These compounds are defined by a specific formula (I), where R1, R2, R3, R4, L, and Z have particular meanings as outlined in the claims. The invention focuses on the prophylaxis and treatment of diseases using these compounds. Another patent also relates to Macrocyclic pyridazinone derivatives, emphasizing their use in the same therapeutic context.

Career Highlights

Serge Christmann-Franck is currently associated with Merck Patent GmbH, where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has led to advancements that could enhance treatment options for patients.

Collaborations

Throughout his career, Serge has collaborated with esteemed colleagues, including Catherine Jorand-Lebrun and Santosh Shripad Kulkarni. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Serge Christmann-Franck is a distinguished inventor whose work in pharmaceuticals has led to the development of valuable compounds. His contributions are poised to make a significant impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…